These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 34217349)

  • 1. Gut microbiota-mediated immunomodulation in tumor.
    Liu X; Chen Y; Zhang S; Dong L
    J Exp Clin Cancer Res; 2021 Jul; 40(1):221. PubMed ID: 34217349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crosstalk between intestinal bacterial microbiota and immune cells in colorectal cancer progression.
    Wen X; Ye X; Yang X; Jiang R; Qian C; Wang X
    Clin Transl Oncol; 2023 Mar; 25(3):620-632. PubMed ID: 36376701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy.
    Kim J; Lee HK
    Mol Cells; 2021 May; 44(5):356-362. PubMed ID: 33972463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold digging: Searching for gut microbiota that enhances antitumor immunity.
    Hou F; Pan Z; Yang R; Zhi F; Bi Y
    J Cell Physiol; 2021 Aug; 236(8):5495-5511. PubMed ID: 33452716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors.
    Simpson RC; Shanahan ER; Scolyer RA; Long GV
    Nat Rev Clin Oncol; 2023 Oct; 20(10):697-715. PubMed ID: 37488231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics.
    Inamura K
    Semin Cancer Biol; 2021 May; 70():11-23. PubMed ID: 32580023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy.
    Yin Q; Ni JJ; Ying JE
    Immun Inflamm Dis; 2024 Jul; 12(7):e1263. PubMed ID: 39031507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
    Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
    Front Immunol; 2021; 12():704942. PubMed ID: 34489956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and immunotherapy of renal cell carcinoma.
    Bibbò S; Porcari S; Del Vecchio LE; Severino A; Mullish BH; Ianiro G; Gasbarrini A; Cammarota G
    Hum Vaccin Immunother; 2023 Dec; 19(3):2268982. PubMed ID: 37955340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Engineered Nanomaterials Affect Immune Responses by Interacting With Gut Microbiota?
    Tang M; Li S; Wei L; Hou Z; Qu J; Li L
    Front Immunol; 2021; 12():684605. PubMed ID: 34594323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Microbiome and Pediatric Cancer: Current Research and Gaps in Knowledge.
    Bhuta R; Nieder M; Jubelirer T; Ladas EJ
    J Natl Cancer Inst Monogr; 2019 Sep; 2019(54):169-173. PubMed ID: 31532533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
    Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
    Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.